Nachrichten zur Pfizer Aktie

Heres How Pfizers Oncology Growth Story Looks Ahead of Q2 Results

PFEs oncology business is in focus ahead of Q2 results as growth from key cancer drugs, biosimilars and pipeline updates…

Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?

The pharma giants yield of around 7.1% is more than six times the S&P 500 average.…

CEO Chat with Dr. Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics

NASDAQ: LABTDavid Bautz, PhD: Welcome to our next episode in our CEO Chat series. My name is David Bautz. Im…

Pfizer Aktie: Droht jetzt neuer Gegenwind?

Charlotte (www.aktiencheck.de) - Pfizer-Aktienanalyse der Bank of America (BofA):BofA habe das Kursziel für die Aktie von Pfizer Inc. (ISIN: US7170811035,…

FDA Expands MRK & PFEs Keytruda-Padcev Combo Use in Bladder Cancer

Mercks Keytruda in combination with Pfizers Padcev wins FDA nod for expanded use in muscle-invasive bladder cancer, regardless of cisplatin…

Pfizer: The AI Hedge That Pays You To Stay Defensive

Pfizer remains an undervalued diversification play, underperforming the benchmark but increasing 2% since prior coverage. Learn why PFE stock is…

Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market?

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication…

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Pfizer Sector Perform

NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Pfizer mit einem Kursziel von 25 US-Dollar…

JPMorgan resets LLY stock target on drug demand

Eli Lilly (LLY) keeps setting records, and Wall Street’s rating of its stock keeps increasing as well.  On Tuesday, one…

Opinion: Pfizers Dividend Is Riskier Than You Might Think

A 7% dividend yield will grab your attention, but be sure to read the fine print.…

Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?

AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer…

Pfizer (PFE) Stock Sinks As Market Gains: Heres Why

Pfizer (PFE) concluded the recent trading session at $23.72, signifying a -2.47% move from its prior days close.…

Jefferies belässt Pfizer auf Buy - Ziel 34 Dollar

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Pfizer mit einem Kursziel von 34 US-Dollar auf "Buy" belassen. Mit…

House committee investigates Merck, AbbVie over China trials

Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China…

Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?

These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.…

Why Pfizer Could Prove to Be an Underrated GLP-1 Stock

It could prove to be a case of better later than never for the healthcare giant.…

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.…

Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.…

2026 Mid-Year Outlook: Big Market Risks, AI And Memory Mania Concerns, And My Top Bargain Stock Picks

Broad market bearishness prompts defensive buys in oversold defense stocks, high-yield Pfizer, and cash reserves. Read more here.…

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and…

Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know

In the most recent trading session, Pfizer (PFE) closed at $24.04, indicating a -2.75% shift from the previous trading day.…

Nike names former Pfizer CFO David Denton as finance chief

Nike Inc (NYSE:NKE, XETRA:NKE) has announced that David Denton will join the company as executive vice president and chief financial…

Pfizer Aktie: Pipelineerfolge dringend notwendig

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?

Lillys GLP-1 leadership, expanding pipeline and strong earnings growth outlook make it a standout pick over Pfizer despite its premium…

BMO reiterates Pfizer stock Outperform on pipeline strength

BMO reiterates Pfizer stock Outperform on pipeline strength…

Pfizer Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Pfizer auf "Neutral" mit einem Kursziel von 27 US-Dollar belassen. Die…

Pfizer Isnt Expecting to Make Any Big Acquisition in the Next Couple of Years, but Its Planning to Do This Instead

The healthcare company is eyeing opportunities related to artificial intelligence, which it believes can enhance its operations.…

Pfizers Dividend Yield is 10X Bigger Than Eli Lillys. Does That Make It the Better Stock for Income Investors?

Pfizer is out of favor right now, and for good reason, but dividend investors may want to take the risk…

PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed

Pfizer shares fall after CFO Dave Denton announces his exit, though the company reaffirms 2026 guidance and maintains its strategic…

ISG-Veranstaltung: Wie Unternehmen ihre Investitionen in KI in messbaren geschäftlichen Nutzen umsetzen

STAMFORD, Conn.--(BUSINESS WIRE)--Die Information Services Group (ISG) (Nasdaq: III), ein weltweit tätiges, auf KI spezialisiertes Technologie- und Beratungsunternehmen, wird Führungskräfte…

Pfizer Aktienanalyse: Schock für Anleger nach CFO-Rücktritt? Warum der Führungswechsel Sorgen auslöst

Bad Marienberg (www.aktiencheck.de)Pfizer Aktie unter Druck: CFO-Rücktritt schockt Anleger - droht jetzt die nächste Bewährungsprobe?Die Aktie von Pfizer Inc. (ISIN:…

Pfizer-Finanzchef geht im August

NEW YORK (dpa-AFX) - Pfizer steht vor einem Wechsel im Finanzressort. Wie der US-Pharmakonzern am…

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer said on Thursday that finance ?chief Dave Denton will step down and leave the company on August 15 to…

Pfizer: Why Im Still Expecting A Massive Rebound

…

The Zacks Analyst Blog Highlights Pfizer, Altria, Newmont, Koil Energy and Stratus Properties

Pfizer, Altria, Newmont, Koil Energy and Stratus Properties are featured for their growth drivers, challenges and recent stock performance.…

Heres When Pfizers CEO Says the Company Might Get Back to Generating High-Single-Digit Growth

Pfizers business may be in better shape than investors think.…

Is Pfizers Discounted Valuation a Buying Opportunity or a Value Trap?

PFE trades at a steep discount as COVID sales fade and patent cliffs loom, but new products, oncology strength and…

Top Research Reports for Pfizer, Altria & Newmont Corp.

Todays Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Altria Group, Inc. (MO) and…

Pfizers New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

The pharmaceutical companys flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.…

Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know

Pfizer (PFE) closed the most recent trading day at $26.14, moving +2.11% from the previous trading session.…

Pfizer upgraded by RBC as valuation resets ahead of key pipeline catalysts

Pfizer upgraded by RBC as valuation resets ahead of key pipeline catalysts…

Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the country. |…

Brandbrief an Merz: Pfizer kritisiert Bundesregierung und überdenkt Investitionen

Pfizer beschäftigt in Deutschland Tausende Menschen und forscht hier seit Jahren. Doch die Pläne der deutschen Gesundheitspolitik bereiten dem Konzern…

Pfizer-Chef sagt Merz ab und stellt Investitionen in Frage

FRANKFURT (dpa-AFX) - Der US-Pharmakonzern Pfizer sagt aus Ärger über Sparvorgaben der Bundesregierung ein Treffen mit Kanzler Friedrich Merz…

Pharmabranche: Pfizer-Chef sagt Merz ab und stellt Investitionen in Frage

Die Kritik an Sparvorgaben für den Pharmasektor wächst: Nach zwei gestoppten Großinvestitionen in Deutschland stellt auch der US-Riese Pfizer Pläne…

Amneal and Pfizer GLP-1 Deal: New Growth Lever?

AMRX is expanding into GLP-1 manufacturing and biosimilars, using partnerships and acquisitions to strengthen its higher-value product strategy.…

RNAZ: Introducing RNA Therapeutics

By John Vandermosten, CFANASDAQ: RNAZREAD THE FULL RNAZ RESEARCH NOTERNA OncologyRibonucleic acid (RNA) oncology is a specialized field in the…

Wall Street Breakfast Podcast: Pfizer Chases Monthly Edge

…

Pfizer’s Berobenatide GLP-1 Obesity Data Might Change The Case For Investing In Pfizer (PFE)

Pfizer Inc. recently presented detailed Phase 2b results for berobenatide (PF’3944), an investigational once-weekly and once-monthly GLP-1 receptor agonist, showing…